|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/44 | (2006.01) |
| A61K 31/519 | (2013.01) | ||
| A61K 31/52 | (2006.01) | ||
| A61K 31/44 | (2013.01) | ||
| A61K 31/4035 | (2006.01) | ||
| A61K 31/52 | (2013.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 11/06 | (2006.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 11/02 | (2018.01) | ||
| A61P 11/06 | (2018.01) | ||
| A61P 11/08 | (2018.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 15/02 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 17/04 | (2018.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 19/10 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 21/04 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 27/14 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/06 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Patento numeris | 2916868 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13795866.6 |
| Europos patento paraiškos padavimo data | 2013-11-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-09-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-05-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2013/059983 |
| Data | 2013-11-07 |
| (87) | Numeris | WO 2014/072937 |
| Data | 2014-05-15 |
| (30) | Numeris | Data | Šalis |
| 2762CH2012 | 2012-11-08 | IN | |
| 4688CH2012 | 2012-11-08 | IN |
| (72) |
VAKKALANKA, Swaroop Kumar Venkata Satya , CH
VISWANADHA, Srikant , IN
|
| (73) |
Rhizen Pharmaceuticals S.A. ,
Fritz Courvoisier 40, 2300 La Chaux de Fonds,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR |
| PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR |